MBX
Ticker
MBX Biosciences, Inc.
MBXMBX Biosciences, Inc. (MBX) has 2 disclosed filings on Paydirt over the trailing twelve months from 2 corporate insiders: 1 purchase and 1 sale. Filers took a median of 3 days from execution to disclosure, and the most recent trade was executed May 8 and filed May 11. The most active filer was Salomon Azoulay with 1 filing. Data as of Nov 8 2026.
Add to watchlistFilings, ttm
2
1 buy · 1 sell
Traders, ttm
2
2 insiders
Volume, ttmiDollar value disclosed in the window
$3.2M
estimated for Congress, as filed for insiders
Median delay
3d
execution to disclosure
Last traded
May 8
Filed May 11
ADViAverage daily dollar volume
–
not on file
Share price · 12M
$66.39 (+171.1%)
Adjusted for splits and dividends.
Volume by month
Buys $17.6M
Sells $2.7M
Estimated for Congress, as filed for insiders · by filing month · past 24 months
Who filed · past 24 months
PH
P. Kent Hawryluk
President & CEO
3 filings · 3 buys, 0 sales
SA
Salomon Azoulay
Chief Medical Officer
1 filing · 0 buys, 1 sale
CGRecent filings
Salomon AzoulaySALE
Chief Medical Officer
$2.7M70,003 sh across 2 lots
Exec May 8
Filed May 11 · 5:30 PM ET P. Kent HawrylukPURCHASE President & CEO $526K
18,500 sh × $28.41
Exec Mar 13
Filed Mar 16 · 8:02 AM ET P. Kent HawrylukPURCHASE President & CEO $273K
20,000 sh × $13.64
Exec Oct 20 2025
Filed Oct 21 2025 · 5:43 PM ET Steven L. HoerterPURCHASE Director $265K
20,000 sh × $13.25
Exec Oct 17 2025
Filed Oct 20 2025 · 4:44 PM ET Patrick J HeronPURCHASE Director $12.0M
666,666 sh × $18.00
Exec Sep 26 2025
Filed Sep 30 2025 · 4:59 PM ET OrbiMed Genesis GP LLCPURCHASE Director $2.0M
190,672 sh across 4 lots
Exec Feb 14 2025
Filed Feb 19 2025 · 5:30 PM ET Carl L GordonPURCHASE Director $2.0M
190,672 sh across 4 lots
Exec Feb 14 2025
Filed Feb 19 2025 · 5:30 PM ET P. Kent HawrylukPURCHASE President & CEO $534K
50,000 sh × $10.69
Exec Feb 4 2025
Filed Feb 5 2025 · 5:30 PM ET